Therapeutic Advances in Chronic Disease
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.7 | Q3 | 46.6% | 0.937 | Q1 | 82.1% |
| 2024 | 2.8 | Q2 | 55.8% | 0.966 | Q1 | 83.3% |
| 2023 | 3.3 | Q2 | 67.6% | 1.031 | Q1 | 86.2% |
| 2022 | 3.5 | Q2 | 64.3% | 0.975 | Q1 | 85.7% |
| 2021 | 5.0 | Q2 | 77.7% | 1.019 | Q1 | 86.9% |
| 2020 | — | — | 1.027 | Q1 | 85.9% | |
| 2019 | — | — | 1.384 | Q1 | 91.5% | |
| 2018 | — | — | 1.516 | Q1 | 92.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2040-6223
ISSN
2040-6231
country
GBcoverage
2010-2026